首页|期刊导航|Fundamental Research|The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide

The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide

Shanqiang Qu Chengying Huang Zhicheng Hu

Fundamental Research2025，Vol.5Issue(4)：P.1822-1830,9.

Fundamental Research2025，Vol.5Issue(4)：P.1822-1830,9.DOI:10.1016/j.fmre.2023.03.005

The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide

Shanqiang Qu ¹Chengying Huang ²Zhicheng Hu³

作者信息

1. Department of Neurosurgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China The Laboratory for Precision Neurosurgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
2. Department of Obstetrics and Gynecology,Nanfang Hospital,Southern Medical University,Guangzhou 510080,China
3. Department of Burn surgery,First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China
折叠

摘要

关键词

Glioma/Biomarker/Therapy/Malignant phenotype/PODNL1

分类

医药卫生

引用本文复制引用

Shanqiang Qu,Chengying Huang,Zhicheng Hu..The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide[J].Fundamental Research,2025,5(4):P.1822-1830,9.

基金项目

supported by the President Foundation of Nanfang Hospital,Southern Medical University(2022A018) （2022A018）

China Postdoctoral Research Foundation(2021M7016). （2021M7016）

Fundamental Research

ISSN：2096-9457

访问量0

下载量0

段落导航